LITTLE FALLS, N.J.--(BUSINESS WIRE)--CANTEL MEDICAL CORP. (NYSE:CMN) reported income from continuing operations of $1,899,000, or $0.12 per diluted share, on a 25% increase in sales to $62,513,000 for the fourth quarter ended July 31, 2007, inclusive of approximately $0.02 in expenses related to recent acquisitions and executive transition, as well as $0.03 of stock-based compensation. This compares with income from continuing operations of $922,000, or $0.06 per diluted share, on sales of $50,140,000 for the fourth quarter ended July 31, 2006, including $0.01 of stock-based compensation expense.
